doi: 10.1136/bmj.o630.
Formula milk companies push allergy products despite flawed evidence
Affiliations
- PMID: 35296503
- PMCID: PMC9879268
- DOI: 10.1136/bmj.o630
Item in Clipboard
Formula milk companies push allergy products despite flawed evidence
BMJ.
.
Abstract
Europe has toughened its approach to formula milk products that claim to reduce allergy risks. But consumers elsewhere continue to be coaxed into buying products that make health claims without high quality evidence. Melanie Newman reports
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Hypoallergenic formulas--when, to whom and how long: after more than 15 years we know the right indication!Allergy. 2004 Aug;59 Suppl 78:45-52. doi: 10.1111/j.1398-9995.2004.00574.x. Allergy. 2004. PMID: 15245358 Review.
-
Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study.Pediatr Allergy Immunol. 2000 Aug;11(3):149-61. doi: 10.1034/j.1399-3038.2000.00081.x. Pediatr Allergy Immunol. 2000. PMID: 10981524 Clinical Trial.
-
The effect of a partially hydrolysed formula based on rice protein in the treatment of infants with cow's milk protein allergy.Pediatr Allergy Immunol. 2010 Jun;21(4 Pt 1):577-85. doi: 10.1111/j.1399-3038.2010.00991.x. Epub 2010 Mar 10. Pediatr Allergy Immunol. 2010. PMID: 20337976 Free PMC article. Clinical Trial.
-
Allergy to soy formula and to extensively hydrolyzed whey formula in infants with cow's milk allergy: a prospective, randomized study with a follow-up to the age of 2 years.J Pediatr. 2002 Feb;140(2):219-24. doi: 10.1067/mpd.2002.121935. J Pediatr. 2002. PMID: 11865274 Clinical Trial.
-
Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in Turkey.Turk J Pediatr. 2016;58(1):1-11. doi: 10.24953/turkjped.2016.01.001. Turk J Pediatr. 2016. PMID: 27922230
References
-
- FTSE Russell. FTSE4Good inclusion criteria for the marketing of breast milk substitutes. Jul 2017. https://research.ftserussell.com/products/downloads/F4G_BMS_Criteria.pdf
-
- Federal Trade Commission. Gerber Products Co, doing business as Nestlé Nutrition, et al. Updated 15 Jul 2019. https://www.ftc.gov/enforcement/cases-proceedings/132-3009-x150016/gerbe...
-
- Castenmiller J, Hirsch-Ernst K-I, Kearney, et al; EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Scientific opinion on the efficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by Société des Produits Nestlé SA in reducing the risk of developing atopic dermatitis. EFSA J 2021;19:6603. https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2021.6603 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
